We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Posterior Lateral Fusion (PLF) With Dynesys

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00791180
First Posted: November 14, 2008
Last Update Posted: September 29, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Zimmer Biomet
  Purpose
The primary purpose of this study is to track and document the clinical outcomes of patients with radicular pathology following posterior lateral fusion with the Dynesys Spinal System. Secondary purpose of this study is to assess outcomes with historical controls along a continuum of motion and anatomy sparing procedures.

Condition
Spondylolisthesis

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Clinical Outcomes Following Posterior Lateral Fusion With the Dynesys(R) Spinal System

Further study details as provided by Zimmer Biomet:

Primary Outcome Measures:
  • Clinical Outcomes [ Time Frame: Pre-op, Surgery, 3 month, 6 month, 12 months and 24 months ]

Secondary Outcome Measures:
  • Surgical Outcomes [ Time Frame: Pre-op, Surgery, 3 months, 6 months, 12 months and 24 months ]

Enrollment: 38
Study Start Date: March 2006
Study Completion Date: March 2011
Primary Completion Date: March 2011 (Final data collection date for primary outcome measure)
Detailed Description:
This study will help the patient to the extent that it will allow the comparison of this unique treatment to the corpus of literature on radicular pathology, thus focusing a specific treatment for a specific pathology.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Clinical outcomes following postierior lateral fusion with the Dynesys(R) Spinal System
Criteria

Inclusion Criteria:

  • Spondylolisthesis of less than Grade II at the index level (degenerative with intact pars)
  • Will receive a decompression for lumbar stenosis
  • Symptoms of leg and/or back pain
  • One pathological level
  • Between the ages of 20 and 80 at the time of surgery
  • Non-responsive to non-surgical treatment for at least six months

Exclusion Criteria:

  • Osteolytic spondylolisthesis
  • Planned complete facetectomy
  • Two or more pathological levels (and as enumerated int he Dynesys Spinal system instructions for use)
  • Use in the cervical spine
  • Active systemic or local infection
  • Extreme obesity as defined by a Body Mass Index (BMI)over 40. BMI calculated using Appendix A, adapted from the National Heart, Lung, and Blood Institute, Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults.
  • Pregnancy
  • Mental illness
  • Severe osteoporosis or osteopenia. The World Health Organization defines osteoporosis as BMD<-2.5t. Professional discretion should be used and if bone quality is in question a DEXA scan is recommended.
  • Sensitivities/allergy to metals, polymers, polyethylene, polycarbonate urethane and polyethylene terephthalate
  • Alcohol or drug abuse
  • Patient unwilling or unable to follow postoperative instructions
  • Soft tissue deficit not allowing sound closure
  • Any medical or physical condition that would preclude the potential benefit of spinal surgery
  • Inadequate pedicles of the lumbar or sacral vertebrae; congenital abnormalities, tumors or other conditions that would prevent secure component fixation that has the potential to decrease the useful life of othe devices;
  • Any medical or mental condition which would exclude the patient at high risk from surgery of the severity
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00791180


Locations
United States, Texas
Foundation Surgical Hospital
Houston, Texas, United States, 77074
Sponsors and Collaborators
Zimmer Biomet
Investigators
Study Director: Jozef Murar, M.D. Zimmer Spine
  More Information

Responsible Party: Zimmer Biomet
ClinicalTrials.gov Identifier: NCT00791180     History of Changes
Other Study ID Numbers: 2006-002
First Submitted: November 13, 2008
First Posted: November 14, 2008
Last Update Posted: September 29, 2011
Last Verified: September 2011

Keywords provided by Zimmer Biomet:
dynamic stabilization
Dynesys
fusion success
Immobilization of spinal segments as an adjunct to fusion in the treatment of the following:
acute and chronic instabilities or deformities of the thoracic, lumbar, and sacral spine
degenerative spondylolisthesis with objective evidence of neurologic impairment
failed previous fusion (pseudarthrosis).

Additional relevant MeSH terms:
Spondylolisthesis
Spondylolysis
Spondylosis
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases